Scarica l'app Stockscreener
11.10
1.93%
0.21
Pre-mercato:
10.78
-0.32
-2.88%
Angiodynamic Inc Borsa (ANGO) Ultime notizie
BlackRock, Inc. Reduces Stake in AngioDynamics Inc - GuruFocus.com
Market Insight: Angiodynamic Inc (ANGO)’s Notable Drop, Closing at 11.04 - The Dwinnex
Angiodynamic Inc (ANGO) receives an Outperform rating from Oppenheimer - Knox Daily
Is it a good time to sell Palantir Technologies Inc [PLTR] shares after an insider sold 4,000 shares? - Knox Daily
Investing in CRH Plc (CRH): What You Must Know - Knox Daily
AngioDynamics Inc. (NASDAQ: ANGO) Reports Narrowed Net Loss and 8% Revenue Decline in Q2 FY2025 - HPBL
AngioDynamics, Inc.'s (NASDAQ:ANGO) Share Price Boosted 38% But Its Business Prospects Need A Lift Too - Simply Wall St
With 74% institutional ownership, AngioDynamics, Inc. (NASDAQ:ANGO) is a favorite amongst the big guns - Yahoo Finance
Assenagon Asset Management S.A. Reduces Holdings in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
AngioDynamics, Inc. (NASDAQ:ANGO) Stock Position Raised by JPMorgan Chase & Co. - Defense World
Barclays PLC Boosts Position in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
**AngioDynamics (NASDAQ:ANGO) Reports Fiscal Second Quarter Results** - Defense World
AngioDynamics Stock Up on Q2 Earnings Beat, Gross Margin Declines - Yahoo Finance
AngioDynamics, Inc. (NASDAQ:ANGO) Q2 2025 Earnings Call Transcript - Insider Monkey
AngioDynamics Reports Growth and Advances NanoKnife System - Yahoo Finance
Institutional investors are AngioDynamics, Inc.'s (NASDAQ:ANGO) biggest bettors and were rewarded after last week's US$154m market cap gain - Simply Wall St
AngioDynamics (NASDAQ:ANGO) Reaches New 52-Week High After Better-Than-Expected Earnings - Defense World
AngioDynamics Inc (ANGO) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
AngioDynamics, Inc. Reports Growth in Med Tech Segment - TipRanks
AngioDynamics Inc Reports Q2 Revenue of $73 Million, Exceeding E - GuruFocus.com
AngioDynamics: A Surgical Approach To Market Growth (NASDAQ:ANGO) - Seeking Alpha
AngioDynamics Hits New 52-Week High Following Strong Earnings Report – Market - HPBL
AngioDynamics hopes NanoKnife will become go-to prostate cancer treatment - Times Union
AngioDynamics Inc. (ANGO) reports earnings - Quartz
AngioDynamics: Fiscal Q2 Earnings Snapshot - The Washington Post
AAR Posts Upbeat Results, Joins AngioDynamics, eBay, Cal-Maine Foods And Other Big Stocks Moving Higher On Wednesday - Benzinga
AngioDynamics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2024 - Marketscreener.com
AngioDynamics (ANGO) reports net loss for Q2 2025; sales drop 8% - AlphaStreet
What To Expect From AngioDynamics Inc (ANGO) Q2 2025 Earnings - GuruFocus.com
AngioDynamics to Showcase Revolutionary NanoKnife Cancer Treatment System at Investor Event - StockTitan
Geode Capital Management LLC Boosts Stock Position in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
Barclays PLC Has $651,000 Stock Position in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
AngioDynamics (NASDAQ:ANGO) vs. Orthofix Medical (NASDAQ:OFIX) Head-To-Head Contrast - Defense World
AngioDynamics, Inc. (NASDAQ:ANGO) Shares Sold by Franklin Resources Inc. - Defense World
Short Interest in AngioDynamics, Inc. (NASDAQ:ANGO) Declines By 12.3% - MarketBeat
State Street Corp Has $6.31 Million Stock Holdings in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
AngioDynamics, Inc. (NASDAQ:ANGO) Stake Raised by Fmr LLC - Defense World
AngioDynamics Sets Date for Q2 Earnings, Unveils Special NanoKnife Investor Event - StockTitan
XTX Topco Ltd Takes $582,000 Position in AngioDynamics, Inc. (NASDAQ:ANGO) - MarketBeat
In-Depth Examination Of 4 Analyst Recommendations For AngioDynamics - Benzinga
There Is A Reason AngioDynamics, Inc.'s (NASDAQ:ANGO) Price Is Undemanding - Simply Wall St
AngioDynamics, Inc. (NASDAQ:ANGO) Stock Position Increased by BNP Paribas Financial Markets - MarketBeat
FDA clears AngioDynamics’ NanoKnife pulsed field ablation system for prostate cancer - Fierce Biotech
AngioDynamics Shares at 52-Week High After FDA Clears NanoKnife - Marketscreener.com
AngioDynamics Secures FDA Clearance for Breakthrough Prostate Cancer Treatment System After Strong Trial Results - StockTitan
Jacobs Levy Equity Management Inc. Sells 95,157 Shares of AngioDynamics, Inc. (NASDAQ:ANGO) - MarketBeat
AngioDynamics Port Defect Caused Infection, Ga. Man Says - Law360
Systematic Financial Management LP Has $18.75 Million Stake in AngioDynamics, Inc. (NASDAQ:ANGO) - MarketBeat
10.10%
0.93%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):